Niveditha Ravindra

9PUBLICATIONS
18CO-AUTHORS
NeurogeneticsMedical virologyMedical infection agents (incl. prions)Haematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 20, 2026
Germline NF2 variant position constrains somatic second hits and determines clinical severity in Neurofibromatosis Type 2-related schwannomatosis.

|Feb 06, 2026
Whole Genome Sequencing Informed Patient Personalized Measurable Residual Disease Assays for Acute Myeloid Leukemia.

Niveditha Ravindra, Justin Lack, Clifton L Dalgard

|Nov 06, 2024
Measurable residual mutated IDH1 before allogeneic transplant for acute myeloid leukemia.

Gege Gui, Niveditha Ravindra, Pranay S Hegde

|Oct 25, 2024
Measurable residual mutated IDH2 before allogeneic transplant for acute myeloid leukemia.

Gege Gui, Niveditha Ravindra, Pranay S Hegde

|Oct 06, 2021
Maternal embryonal leucine zipper kinase immunoreactivity in atypical teratoid/rhabdoid tumors: a study of 50 cases.

N Ravindra, S Rao, A Arivazhagan

|Jul 02, 2020
Novel frameshift variant (c.409dupG) in SLC25A38 is a common cause of congenital sideroblastic anaemia in the Indian subcontinent.

Niveditha Ravindra, Rekha Athiyarath, Eswari S

Pageof 2

Frequent Collaborators

6 joint publications

Laura W Dillon

4 joint publications

Jeffery J Auletta

4 joint publications

Steven M Devine

4 joint publications

Antonio Martin Jimenez Jimenez